These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12834011)

  • 21. Relevant hepatotoxic effects of kava still need to be proven. A statement of the Society for Medicinal Plant Research.
    Society for Medicinal Plant Research
    Planta Med; 2003 Nov; 69(11):971-2. PubMed ID: 14735431
    [No Abstract]   [Full Text] [Related]  

  • 22. Kava Hepatotoxicity: Are we any closer to the truth?
    Anke J; Ramzan I
    Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2012 Mar; (571):1-186. PubMed ID: 22441424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.
    Nerurkar PV; Dragull K; Tang CS
    Toxicol Sci; 2004 May; 79(1):106-11. PubMed ID: 14737001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kava, the anxiolytic herb: back to basics to prevent liver injury?
    Teschke R; Sarris J; Glass X; Schulze J
    Br J Clin Pharmacol; 2011 Mar; 71(3):445-8. PubMed ID: 21284704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kava lactones and the kava-kava controversy.
    Whitton PA; Lau A; Salisbury A; Whitehouse J; Evans CS
    Phytochemistry; 2003 Oct; 64(3):673-9. PubMed ID: 13679089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis induced by Kava (Piper methysticum rhizoma).
    Stickel F; Baumüller HM; Seitz K; Vasilakis D; Seitz G; Seitz HK; Schuppan D
    J Hepatol; 2003 Jul; 39(1):62-7. PubMed ID: 12821045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports.
    Teschke R; Glass X; Schulze J
    Regul Toxicol Pharmacol; 2011 Dec; 61(3):282-91. PubMed ID: 21893153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.
    Pantano F; Tittarelli R; Mannocchi G; Zaami S; Ricci S; Giorgetti R; Terranova D; Busardò FP; Marinelli E
    Int J Mol Sci; 2016 Apr; 17(4):580. PubMed ID: 27092496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.
    Tugcu G; Kırmızıbekmez H; Aydın A
    Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia.
    Russmann S; Barguil Y; Cabalion P; Kritsanida M; Duhet D; Lauterburg BH
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1033-6. PubMed ID: 12923378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?].
    Teschke R
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1880-1; author reply 1882-3. PubMed ID: 16915552
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxicity of kava pyrones, drug safety and precautions--a case study.
    Schulze J; Raasch W; Siegers CP
    Phytomedicine; 2003; 10 Suppl 4():68-73. PubMed ID: 12807347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of ethanolic kava extract: Results of a study of chronic toxicity in rats.
    Sorrentino L; Capasso A; Schmidt M
    Phytomedicine; 2006 Sep; 13(8):542-9. PubMed ID: 16904878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.